Genome-wide Rare Copy Number Variation Screening in Ulcerative Colitis Identifies Potential Susceptibility Loci
Overview
Authors
Affiliations
Background: Ulcerative colitis (UC), a complex polygenic disorder, is one of the main subphenotypes of inflammatory bowel disease. A comprehensive dissection of the genetic etiology of UC needs to assess the contribution of rare genetic variants including copy number variations (CNVs) to disease risk. In this study, we performed a multi-step genome-wide case-control analysis to interrogate the presence of disease-relevant rare copy number variants.
Methods: One thousand one hundred twenty-one German UC patients and 1770 healthy controls were initially screened for rare deletions and duplications employing SNP-array data. Quantitative PCR and high density custom array-CGH were used for validation of identified CNVs and fine mapping. Two main follow-up panels consisted of an independent cohort of 451 cases and 1274 controls, in which CNVs were assayed through quantitative PCR, and a British cohort of 2396 cases versus 4886 controls with CNV genotypes based on array data. Additional sample sets were assessed for targeted and in silico replication.
Results: Twenty-four rare copy number variants (14 deletions and 10 duplications), overrepresented in UC patients were identified in the initial screening panel. Follow-up of these CNV regions in four independent case-control series as well as an additional public in silico control group (totaling 4439 UC patients and 15,961 healthy controls) revealed three copy number variants enriched in UC patients; a 15.8 kb deletion upstream of ABCC4 and CLDN10 at13q32.1 (0.43% cases, 0.11% controls), a 119 kb duplication at 7p22.1, overlapping RNF216, ZNF815, OCM and CCZ1 (0.13% cases, 0.01% controls) and a 134 kb large duplication upstream of the KCNK9 gene at 8q24.3 (0.22% carriers among cases, 0.03% carriers among controls). The trend of association with UC was present after the P-values were corrected for combining data from different subpopulations. Break-point mapping of the deleted region suggested non-allelic homologous recombination as the mechanism underlying its formation.
Conclusion: Our study presents a pragmatic approach for effective rare CNV screening of SNP-array data sets and implicates the potential contribution of rare structural variants in the pathogenesis of UC.
Pathological mechanism and targeted drugs of ulcerative colitis: A review.
Guo M, Wang X Medicine (Baltimore). 2023; 102(37):e35020.
PMID: 37713856 PMC: 10508406. DOI: 10.1097/MD.0000000000035020.
Research trends of omics in ulcerative colitis: A bibliometric analysis.
Zhang H, Ni Y, Ji H, Liu H, Liu S Front Med (Lausanne). 2023; 10:1115240.
PMID: 37051213 PMC: 10083299. DOI: 10.3389/fmed.2023.1115240.
Dirvanskyte P, Gurram B, Bolton C, Warner N, Jones K, Griffin H J Crohns Colitis. 2022; 17(1):49-60.
PMID: 35907265 PMC: 9880952. DOI: 10.1093/ecco-jcc/jjac103.
An Update Evolving View of Copy Number Variations in Autoimmune Diseases.
Song R, Gao C, Zhao J, Zhang J Front Genet. 2022; 12:794348.
PMID: 35126462 PMC: 8810490. DOI: 10.3389/fgene.2021.794348.
Pos O, Radvanszky J, Buglyo G, Pos Z, Rusnakova D, Nagy B Biomed J. 2021; 44(5):548-559.
PMID: 34649833 PMC: 8640565. DOI: 10.1016/j.bj.2021.02.003.